AstraZeneca PLCChange company Symbol lookupSelect an option...AZN AstraZeneca PLCPTON Peloton Interactive IncETR Entergy CorpACMR ACM Research IncRGAGX American Funds The Growth Fund of America® Class R-6ATRC AtriCure IncCTRA Coterra Energy IncCINF Cincinnati Financial CorpATOM Atomera IncIEAWW Infrastructure and Energy Alternatives 27 March 2023 *W EXP 03/27/2023Go
Based in United Kingdom
AstraZeneca PLC is a patient-focused pharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines. The Company is focused on various therapy areas, such as Oncology; BioPharmaceuticals (comprising Cardiovascular, Renal & Metabolism (CVRM) and Respiratory & Immunology (R&I)), and Rare Disease. Its pipeline forms a robust portfolio of investigational therapies in various stages of clinical development. Its pipeline includes the Alexion Rare Disease portfolio and comprises approximately 177 projects, of which 161 are in the clinical phase of development. Its key marketed oncology products include Tagrisso (osimertinib), Lynparza (olaparib), Imfinzi (durvalumab), Koselugo (selumetinib), Farxiga/ Forxiga (dapagliflozin), Roxadustat, Onglyza (saxagliptin) and others. The Company’s geographical segments include United Kingdom, Rest of Europe, The Americas and Asia, Africa & Australasia.
American Depositary Receipt (ADR) Fee
ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees
|
|
|
|
| |
Upcoming Events
Past Earnings
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
| Date | Event description | Earnings per share actual | Earnings estimate range | Previous year's actual |
|---|---|---|---|---|
| April 29, 2022 | Q1 2022 Earnings Release | $0.95 | $0.83 to $0.83 | $0.82 |
| February 10, 2022 | Q4 2021 Earnings Release | $0.84 | $0.69 to $0.77 | $0.535 |
| November 12, 2021 | Q3 2021 Earnings Release | $0.54 | $0.62 to $0.62 | $0.47 |
| July 29, 2021 | Q2 2021 Earnings Release | $0.45 | $0.43 to $0.43 | $0.48 |
Past Dividends
| Ex-dividend date | Amount | Record date | Pay date |
|---|---|---|---|
| February 24, 2022 | $0.985 | February 25, 2022 | March 28, 2022 |
| August 12, 2021 | $0.45 | August 13, 2021 | September 13, 2021 |
Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.
, , , Copyright © 2022. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.